U.S. Food and Drug Administration (FDA) is currently investigating products from Indian spice makers MDH and Everest. This comes after Hong Kong halted sales of certain products from these brands due to concerns about high levels of a cancer-causing pesticide.
An FDA spokesperson stated that they are aware of the situation and are actively collecting more information.
Hong Kong recently suspended sales of three MDH spice blends and one Everest spice mix, particularly for fish curries, due to these concerns.
Singapore has also taken action, ordering a recall of the Everest spice mix. They cited high levels of ethylene oxide, a substance deemed unfit for human consumption and associated with cancer risks with prolonged exposure.
Both MDH and Everest have not yet responded to requests for comment. However, Everest has previously stated that its spices are safe for consumption.
These spice brands, widely recognized in India and sold internationally in Europe, Asia, and North America, are also being scrutinized by Indian regulators for their adherence to quality standards. This follows the actions taken by Hong Kong and Singapore.
European Union food safety authorities have identified cancer-causing chemicals in 527 food products originating from India.
Update:
The Indian food safety regulator is expanding its crackdown on spices, announcing plans to conduct nationwide checks on all spice makers amidst global scrutiny, according to a statement from the officials.
